首页 › 股票 › KALV

KALV — KALVISTA PHARMACEUTICALS INC

申报持仓市值$1.68B
持有基金数(最新)296
板块—

什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么

持有机构数 (Q2 2026)1
机构持仓市值$189 · 7 股
新建/增持/减仓/清仓1 / 0 / 0 / 191 · 更新于 2026-10-24
前五大/前十大集中度100.0% / 100.0%

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

截至Q2 2026,共 1 家机构在其最新 13F 申报中持有 KALV(KALVISTA PHARMACEUTICALS INC),合计申报市值 $189,对应 7 股。持仓集中度较高:前五大持有人占申报市值的 100.0%,前十大的集中度为 100.0%。

与上一季度相比,1 家新建仓位、191 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。

KALVISTA PHARMACEUTICALS INC(KALV)的主要机构持有人包括 Venrock Adviser, LLC、Frazier Life Sciences Management, L.P.、MONTANOVA CAPITAL, LLC,按 13F 申报市值在本页 296 家持有人中排名居前。

本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。

机构逐季持仓趋势

季度 持有机构数 股数 金额 环比净变动
Q2 2026 1 7 $189 —
Q1 2026 191 74.32M $1.50B +6.4%
Q4 2025 164 67.77M $1.09B +1.0%
Q3 2025 148 62.15M $756.79M +4.5%
Q2 2025 141 57.78M $653.03M -0.8%
Q1 2025 134 58.21M $677.06M -0.4%
Q4 2024 128 58.05M $491.53M +9.6%
Q3 2024 121 50.26M $582.14M +4.4%

表内 8 个季度中,机构持股合计减少 100%(Q3 2024 → Q2 2026);单季变动最大的是 Q4 2024(+9.6%)。

前 25 大机构持仓人(Q2 2026) — 1 家基金

基金股数金额组合权重变化
IFP Advisors, Inc 7 $189 0.00% 新进

↑ 返回持仓列表顶部

更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人

Q1 2026 — 25 家基金

基金股数金额组合权重变化
Venrock Adviser, LLC 6.47M $130.33M 4.87% 减持
Frazier Life Sciences Management, L.P. 4.96M $99.87M 2.57% 减持
MONTANOVA CAPITAL, LLC 4.77M $95.99M 2.45% 持有
TANG CAPITAL MANAGEMENT LLC 4.57M $92.07M 4.68% 持有
BlackRock Inc 3.80M $76.41M 0.00% 增持
SILVERARC CAPITAL MANAGEMENT, LLC 2.88M $57.90M 7.19% 增持
Capital World Investors 2.81M $56.54M 0.01% 持有
Capital World Investors 2.81M $56.54M 0.01% 持有
Point72 Asset Management 2.14M $43.02M 0.17% 减持
STATE STREET CORP 1.96M $39.37M 0.00% 增持
Millennium Management 1.91M $38.49M 0.02% 减持
MILLENNIUM MANAGEMENT LLC 1.91M $38.49M 0.05% 增持
Vestal Point Capital, LP 1.85M $37.24M 1.04% 减持
Parkman Healthcare Partners LLC 1.84M $36.95M 3.81% 增持
VANGUARD CAPITAL MANAGEMENT LLC 1.83M $36.85M 0.00% 新进
Kynam Capital Management, LP 1.82M $36.66M 2.36% 增持
Woodline Partners LP 1.51M $30.39M 0.12% 减持
Octagon Capital Advisors LP 1.45M $29.19M 3.23% 增持
EMERALD ADVISERS, LLC 1.26M $25.44M 0.81% 减持
ARMISTICE CAPITAL, LLC 1.24M $24.88M 0.49% 增持
Elmind Capital, LP 1.02M $20.56M 5.84% 增持
Caption Management, LLC 1.00M $20.13M 0.39% 增持
Geode Capital Management 996.24K $20.06M 0.00% 增持
Spruce Street Capital LP 897.68K $18.07M 4.34% 增持
Freestone Grove Partners LP 882.91K $17.77M 0.13% 增持

Q4 2025 — 25 家基金

基金股数金额组合权重变化
Venrock Adviser, LLC 6.73M $108.67M 5.37% 持有
Frazier Life Sciences Management, L.P. 5.04M $81.39M 2.19% 持有
MONTANOVA CAPITAL, LLC 4.77M $77.01M 1.58% 持有
TANG CAPITAL MANAGEMENT LLC 4.57M $73.86M 3.65% 减持
BlackRock Inc 3.75M $60.63M 0.00% 增持
Millennium Management 2.92M $47.16M 0.02% 增持
Capital World Investors 2.81M $45.36M 0.01% 减持
Capital World Investors 2.81M $45.36M 0.01% 减持
Vanguard Group 2.51M $40.52M 0.00% 持有
Point72 Asset Management 2.28M $36.88M 0.14% 新进
Woodline Partners LP 1.92M $31.03M 0.12% 持有
STATE STREET CORP 1.91M $30.87M 0.00% 增持
Vestal Point Capital, LP 1.89M $30.52M 1.04% 增持
Kynam Capital Management, LP 1.81M $29.25M 1.95% 增持
Parkman Healthcare Partners LLC 1.77M $28.56M 2.72% 增持
EMERALD ADVISERS, LLC 1.34M $21.65M 0.67% 减持
Octagon Capital Advisors LP 1.27M $20.56M 2.50% 持有
SCHRODER INVESTMENT MANAGEMENT GROUP 1.17M $18.92M 0.01% 增持
Geode Capital Management 944.08K $15.25M 0.00% 增持
EMERALD MUTUAL FUND ADVISERS TRUST 855.46K $13.82M 0.67% 减持
Goldman Sachs Group 835.30K $13.49M 0.01% 减持
Elmind Capital, LP 801.30K $12.94M 3.82% 新进
ARMISTICE CAPITAL, LLC 800.00K $12.92M 0.16% 新进
BARCLAYS PLC 700.57K $11.31M 0.01% 增持
Morgan Stanley 700.23K $11.31M 0.00% 增持

Q3 2025 — 25 家基金

基金股数金额组合权重变化
Venrock Adviser, LLC 6.73M $81.96M 4.61% 持有
TANG CAPITAL MANAGEMENT LLC 5.04M $61.41M 2.36% 增持
Frazier Life Sciences Management, L.P. 5.04M $61.39M 1.84% 增持
MONTANOVA CAPITAL, LLC 4.77M $58.08M 1.50% 减持
Capital World Investors 3.18M $38.70M 0.01% 持有
Capital World Investors 3.18M $38.70M 0.01% 持有
BlackRock Inc 3.13M $38.08M 0.00% 持有
Vanguard Group 2.50M $30.46M 0.00% 增持
Millennium Management 2.12M $25.78M 0.01% 增持
Woodline Partners LP 1.92M $23.39M 0.11% 持有
Goldman Sachs Group 1.80M $21.93M 0.01% 增持
Parkman Healthcare Partners LLC 1.74M $21.13M 2.20% 增持
STATE STREET CORP 1.58M $19.19M 0.00% 增持
SILVERARC CAPITAL MANAGEMENT, LLC 1.36M $16.61M 2.35% 减持
EMERALD ADVISERS, LLC 1.35M $16.46M 0.53% 增持
Octagon Capital Advisors LP 1.27M $15.51M 2.42% 持有
SCHRODER INVESTMENT MANAGEMENT GROUP 1.16M $14.14M 0.01% 增持
Geode Capital Management 928.67K $11.31M 0.00% 减持
EMERALD MUTUAL FUND ADVISERS TRUST 917.98K $11.18M 0.58% 增持
Vestal Point Capital, LP 750.00K $9.13M 0.41% 减持
Freestone Grove Partners LP 704.45K $8.58M 0.06% 新进
Sio Capital Management, LLC 683.82K $8.33M 2.11% 新进
Kynam Capital Management, LP 606.17K $7.38M 0.55% 新进
BNY Mellon 596.47K $7.27M 0.00% 增持
BARCLAYS PLC 577.90K $7.04M 0.01% 增持

Q2 2025 — 25 家基金

基金股数金额组合权重变化
Venrock Adviser, LLC 6.73M $76.07M 5.70% 持有
MONTANOVA CAPITAL, LLC 4.96M $56.02M 1.73% 增持
TANG CAPITAL MANAGEMENT LLC 4.94M $55.87M 2.82% 持有
Frazier Life Sciences Management, L.P. 4.89M $55.26M 2.21% 持有
Vestal Point Capital, LP 4.67M $52.85M 2.78% 减持
Capital World Investors 3.18M $35.92M 0.01% 持有
Capital World Investors 3.18M $35.92M 0.01% 持有
BlackRock Inc 3.13M $35.38M 0.00% 减持
Vanguard Group 2.41M $27.27M 0.00% 增持
Woodline Partners LP 1.92M $21.71M 0.12% 增持
SILVERARC CAPITAL MANAGEMENT, LLC 1.83M $20.71M 4.28% 增持
STATE STREET CORP 1.35M $15.26M 0.00% 增持
Octagon Capital Advisors LP 1.27M $14.40M 3.16% 减持
EMERALD ADVISERS, LLC 1.04M $11.74M 0.43% 增持
AMERIPRISE FINANCIAL INC 945.12K $10.68M 0.00% 增持
Geode Capital Management 941.21K $10.64M 0.00% 增持
EMERALD MUTUAL FUND ADVISERS TRUST 768.97K $8.69M 0.53% 增持
Parkman Healthcare Partners LLC 679.06K $7.68M 0.88% 减持
DAFNA Capital Management LLC 581.76K $6.58M 1.88% 减持
SCHRODER INVESTMENT MANAGEMENT GROUP 554.96K $6.27M 0.01% 减持
Millennium Management 430.63K $4.87M 0.00% 增持
STEMPOINT CAPITAL LP 386.79K $4.37M 1.59% 增持
Bank of America Corp 366.97K $4.15M 0.00% 增持
Northern Trust Corp 352.15K $3.98M 0.00% 减持
GREAT POINT PARTNERS LLC 323.17K $3.65M 2.38% 减持

Q1 2025 — 25 家基金

基金股数金额组合权重变化
Venrock Adviser, LLC 6.70M $77.36M 6.58% 增持
TANG CAPITAL MANAGEMENT LLC 4.94M $57.03M 3.15% 增持
MONTANOVA CAPITAL, LLC 4.91M $56.70M 2.10% 持有
Frazier Life Sciences Management, L.P. 4.89M $56.41M 2.58% 持有
Vestal Point Capital, LP 4.75M $54.83M 3.92% 持有
Capital World Investors 3.18M $36.67M 0.01% 减持
Capital World Investors 3.18M $36.67M 0.01% 减持
BlackRock Inc 3.15M $36.37M 0.00% 增持
Vanguard Group 2.30M $26.53M 0.00% 增持
SILVERARC CAPITAL MANAGEMENT, LLC 1.70M $19.61M 4.11% 增持
Woodline Partners LP 1.62M $18.67M 0.12% 增持
Octagon Capital Advisors LP 1.37M $15.81M 3.19% 持有
STATE STREET CORP 1.09M $12.62M 0.00% 减持
GREAT POINT PARTNERS LLC 1.01M $11.71M 6.20% 减持
Geode Capital Management 915.24K $10.56M 0.00% 增持
EMERALD ADVISERS, LLC 898.19K $10.37M 0.47% 增持
SCHRODER INVESTMENT MANAGEMENT GROUP 868.01K $10.36M 0.01% 增持
Parkman Healthcare Partners LLC 753.75K $8.70M 1.03% 新进
DAFNA Capital Management LLC 752.36K $8.68M 2.55% 减持
DIMENSIONAL FUND ADVISORS LP 645.99K $7.46M 0.00% 减持
EMERALD MUTUAL FUND ADVISERS TRUST 608.21K $7.02M 0.50% 增持
Schonfeld Strategic Advisors LLC 581.75K $6.71M 0.05% 新进
UBS Group AG 507.70K $5.86M 0.00% 增持
Caption Management, LLC 450.00K $5.19M 0.14% 新进
Nuveen, LLC 37.32K $4.93M 0.00% 新进

查看全部 296 家持有基金 →

新建仓(Q2 2026)

完全清仓(较上季)

基金持仓历史 — 各季度股数(前 20 只基金)

基金Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
IFP Advisors, Inc 7 — — 5 — 4 4 — — — — — — — — — — — — —
Venrock Adviser, LLC — 6.47M 6.73M 6.73M 6.73M 6.70M 6.25M 6.25M 6.25M 6.25M 4.09M 2.92M — — — — — — — —
Frazier Life Sciences Management, L.P. — 4.96M 5.04M 5.04M 4.89M 4.89M 4.89M 3.69M 3.69M 3.69M 3.62M 3.24M — — — — — — — —
MONTANOVA CAPITAL, LLC — 4.77M 4.77M 4.77M 4.96M 4.91M 4.91M 4.21M 4.19M 4.19M 2.68M 2.42M — — — — — — — —
TANG CAPITAL MANAGEMENT LLC — 4.57M 4.57M 5.04M 4.94M 4.94M 4.89M 4.32M 4.22M 4.13M 3.44M 3.44M — — — — — — — —
BlackRock Inc — 3.80M 3.75M 3.13M 3.13M 3.15M 2.86M 3.06M — — — — — — — — — — — —
SILVERARC CAPITAL MANAGEMENT, LLC — 2.88M 290.60K 1.36M 1.83M 1.70M 612.17K 574.56K 560.88K 561.18K 111.73K 228.93K — — — — — — — —
Capital World Investors — 2.81M 2.81M 3.18M 3.18M 3.18M 3.37M 3.37M 3.23M 1.46M — — — — — — — — — —
Capital World Investors — 2.81M 2.81M 3.18M 3.18M 3.18M 3.37M 3.37M 3.23M 1.46M — — — — — — — — — —
Vestal Point Capital, LP — 1.85M 1.89M 750.00K 4.67M 4.75M 4.77M 4.00M 2.30M 655.00K — — — — — — — — — —
Millennium Management — 1.91M 2.92M 2.12M 430.63K 198.21K — — — 19.33K 50.00K — 77.94K 80.70K 576.25K 477.96K 100.32K 17.15K — 36.72K
Point72 Asset Management — 2.14M 2.28M — — — — — — — — — — — — 57.80K — — — —
TCG Crossover Management, LLC — — — — — — — — — 1.16M 3.40M 3.40M — — — — — — — —
Vanguard Group — — 2.51M 2.50M 2.41M 2.30M 2.26M 2.15M 1.99M 1.69M 1.78M 1.73M 1.58M 1.58M 1.15M 1.15M 1.16M 1.17M 1.14M 1.19M
STATE STREET CORP — 1.96M 1.91M 1.58M 1.35M 1.09M 1.39M 1.27M 756.43K 594.17K 537.10K 459.35K — — — — — — — —
MILLENNIUM MANAGEMENT LLC — 1.91M 23.50K 20.00K 90.00K 198.21K — — — 19.33K 50.00K — — — — — — — — —
Parkman Healthcare Partners LLC — 1.84M 1.77M 1.74M 679.06K 753.75K — — — — — — — — — — — — — —
VANGUARD CAPITAL MANAGEMENT LLC — 1.83M — — — — — — — — — — — — — — — — — —
Kynam Capital Management, LP — 1.82M 1.81M 606.17K — — — — — — — — — — — — — — — —
Woodline Partners LP — 1.51M 1.92M 1.92M 1.92M 1.62M 1.29M 608.25K 150.46K 150.46K 346.86K — — — — — — — — —

下载持有人名单 (CSV)

常见问题

Which funds hold KALV?

As of 2026-Q2, 1 institutional funds reported holding KALV (KALVISTA PHARMACEUTICALS INC) in SEC 13F filings, with a combined reported value of $189.

How many shares of KALV do institutions own?

13F filers reported 7 shares of KALV, worth $189 in aggregate at the end of 2026-Q2.

Is institutional ownership of KALV rising or falling?

No prior-quarter baseline is available for a directional read.

Who are the top institutional holders of KALV?

The largest 13F holders are Venrock Adviser, LLC, Frazier Life Sciences Management, L.P., MONTANOVA CAPITAL, LLC, TANG CAPITAL MANAGEMENT LLC, BlackRock Inc; the top 25 are ranked at the top of this page.

Who are the major shareholders of KALVISTA PHARMACEUTICALS INC?

The major shareholders of KALVISTA PHARMACEUTICALS INC (KALV) by reported 13F value are Venrock Adviser, LLC, Frazier Life Sciences Management, L.P., MONTANOVA CAPITAL, LLC, TANG CAPITAL MANAGEMENT LLC, BlackRock Inc, among 296 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

将本股票嵌入你的网站

复制下面的代码,即可在你的博客或论坛上展示「哪些传奇投资人持有 KALV」的实时名单——免费、自动更新、回链 HoldingsHub。

<iframe src="https://holdingshub.top/stocks/KALV/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

预览可嵌入组件 →